Viewing Study NCT04443751


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-28 @ 1:05 AM
Study NCT ID: NCT04443751
Status: COMPLETED
Last Update Posted: 2023-08-24
First Post: 2020-06-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module